Together with our experimental data, the bioinformatic analyses suggested that high EHMT and EZH2 activity contribute to the T-cell poor cold immune phenotype of high-risk NBs with MYCN amplification providing a rationale for targeted epigenetic immunomodulation. This evidence concerns the gene EZH2 and Nijmegen breakage syndrome.